Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 30, 1997
Issued Date -
N/A
app pub date -
Dec 22, 1993
filing date -
Aug 22, 1989
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Nucleic acid sequences encoding the Bovine Coronavirus E2 (or BCV S) and E3 (or BCV HE) structural glycoproteins and methods of producing these proteins, including recombinant expression, e.g., in mammalian or insect cells, are provided. The E2 and E3 proteins or antigenic fragments thereof are useful components for Bovine Coronavirus vaccines and methods of treatment.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully